D Brat - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

D Brat

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Cancer Research|May 8, 1999

Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumorsP Sampath, J Hanes, F DiMeco, et al.

The American Journal of Pathology|March 10, 2001

Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groupsY Hirose, K Aldape, A Bollen, et al.

Journal of Neurosurgery|March 4, 2000

Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in ratsF DiMeco, L D Rhines, J Hanes, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000

Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous systemM G Ewend, R C Thompson, R Anderson, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Cancer Research|May 8, 1999

Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumorsP Sampath, J Hanes, F DiMeco, et al.

The American Journal of Pathology|March 10, 2001

Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groupsY Hirose, K Aldape, A Bollen, et al.

Journal of Neurosurgery|March 4, 2000

Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in ratsF DiMeco, L D Rhines, J Hanes, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000

Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous systemM G Ewend, R C Thompson, R Anderson, et al.

Pageof 1